台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    59.0
  • 漲跌
    ▲0.1
  • 漲幅
    +0.17%
  • 成交量
    76
  • 產業
    上櫃 生技醫療類股
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
東生華 (8432)籌碼相關-統一-新竹 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

統一-新竹 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/08/22258.3000.0058.0021761.13%
2024/08/19258.0000.0057.9021861.07%
2024/08/16358.5000.0057.8031871.60%
2024/08/15557.5000.0058.2051912.62%
2024/06/2400.00166.9068.50-1225-0.44%
2024/06/06166.0000.0067.1012170.46%
2024/05/20267.70266.7567.9003070.00%
2024/03/0100.001264.5463.80-12220-5.45%
2024/02/2700.00163.0064.30-1216-0.46%
2024/02/231363.2100.0061.00132026.42%
2024/02/2100.00861.9061.90-8182-4.39%
2024/02/19357.4700.0056.0031611.85%
2024/02/16557.8200.0057.2051613.10%
2024/01/1000.00552.3051.90-5423-1.18%
2023/11/1400.00450.6551.00-4333-1.20%
2023/11/1300.00150.1050.30-1327-0.31%
2023/11/09255.15256.9553.5002980.00%
2023/11/08356.2000.0056.4032781.08%
2023/11/07257.85258.6057.9002560.00%
2023/11/06254.40354.6054.80-1209-0.48%
2023/11/03352.93356.1052.0001730.00%
2023/11/02350.7300.0051.0031162.57%
2023/10/3100.001048.4047.25-1056-17.61%
2023/10/30947.83148.9048.7085414.79%
2023/09/2600.00145.3045.45-172-1.37%
2023/09/1900.00146.0546.10-174-1.34%
2023/08/16145.6000.0045.451811.23%
2023/07/19250.20250.0049.850620.00%
2023/07/18247.1000.0047.052484.15%
2023/07/1200.00246.8046.55-243-4.60%
2023/06/14245.8500.0045.902395.08%
2023/05/03246.0000.0046.102573.47%
2023/04/2000.001145.8945.80-1155-19.79%
2023/03/17346.9700.0047.303763.92%
2023/03/16247.0000.0046.852772.59%
2023/03/15647.9300.0047.756787.69%
2022/12/0600.00246.9346.25-295-2.09%
2022/09/0700.00348.1548.80-3272-1.10%
2022/08/02746.11244.9044.6051533.27%
2022/05/0500.00144.2544.25-150-1.98%
2022/03/30143.2500.0043.401422.38%
2021/11/2600.00144.8044.65-198-1.01%
2021/11/2300.00844.0143.95-897-8.24%
2021/11/03144.2000.0044.251901.10%
2021/07/19241.4000.0041.4022290.87%
2021/06/29142.7500.0042.9512380.42%
2021/06/28143.5000.0043.3512370.42%
2021/06/22143.0500.0043.0012340.43%
2021/06/21143.9500.0044.2012300.43%
2021/06/18144.4000.0045.2012270.44%
2021/06/16145.4500.0044.7012230.45%
2021/06/1100.00345.6744.95-3220-1.36%
2021/06/01143.1500.0043.3011900.53%
2021/05/27143.0500.0043.0511820.55%
2021/05/2000.00143.6042.10-1172-0.58%
2021/05/19145.1500.0043.5011670.60%
2021/05/12141.4500.0040.9011320.76%
2020/06/15166.2000.0066.201631.57%
2020/05/1100.000.168.8068.80-0.135-0.40%
2020/01/1600.000.178.8078.80-0.124-0.29%
2019/08/2000.00176.2076.00-140-2.47%
2018/08/0100.00289.3589.20-2148-1.35%
2018/07/2000.00282.0081.10-2198-1.01%
2018/07/17281.05180.5080.1013240.31%
2018/06/2000.00175.8075.40-1424-0.24%
2018/05/31168.8000.0069.1014230.24%
2018/05/22170.7000.0070.0014270.23%
2018/04/27181.1000.0080.1014220.24%
2018/04/26188.50193.5089.0004090.00%
2018/04/25191.5000.0090.0013840.26%
2018/04/24290.50293.7093.3003330.00%
2018/04/2300.00392.0393.80-3298-1.01%
2018/04/2000.00289.0085.30-2275-0.73%
2018/01/16166.9000.0067.101751.33%
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華法說會/併購高峰、三大業務加持 今年營收拚增五成達12億UDN聯合新聞網-2024/03/25
東生華 相關文章